Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BI-2536

Inh 755038-02-9 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
Produktnummer ABIN7233234

Kurzübersicht für BI-2536 (ABIN7233234)

Applikation

Inhibition (Inh)

Chemical Name

4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
  • Verwendungszweck

    Dual Plk/BRD4 inhibitor, Destabilizes Myc

    Produktmerkmale

    BI 2536 was originally reported as a potent (IC50's Plk1 = 0.83nM, Plk2 = 3.5nM and Plk3 = 9.0nM) and selective2 Polo-like kinase inhibitor (IC50's Plk1 = 0.83nM, Plk2 = 3.5nM and Plk3 = 9.0nM) that caused mitotic arrest and apoptosis induction in various human cancer cell lines. It was later found to be a potent inhibitor (IC50 = 100nM) of BET family member BRD4 and able to potently suppress c-Myc expression in MM.1S multiple myeloma cells. BI 2536 destabilizes N-Myc by inhibiting the deactivation of the ubiquitin E3 ligase Fbw7 by Plk1.

    Reinheit

    >97 %

    Formel

    C28H39N7O3

    Löslichkeit

    Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 25 mg/ml)
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Powder

    Lagerung

    -20 °C
  • Hintergrund

    Apoptosis inducer,Epigenetics,Cell cycle,Myc,Bromodomain,Ubiquitin/Proteasome,Cell death,Cancer,Posttranslational modification,Chromatin

    Molekulargewicht

    521.67

    CAS-Nummer

    755038-02-9
Sie sind hier:
Chat with us!